USA: Attorney General accused of harassing cannabis companies
No laws were broken, but the event serves as a reminder to American companies of the Cannabis that the federal government can still interfere in their business transactions.
General Counsel William Barr has thus forced companies to produce thousands of documents costing millions of dollars, the review of which slowed down certain operations, if not completely scuttling the announced merger between MedMen and PharmaCann.
A whistleblower working at the Department of Justice, John Elis, said that these requests had more to do with Attorney General William Barr's personal views on the cannabis trade than with a need to monitor possible monopoly positions that cannot exist today in the US cannabis market.
John Elias testified before the House Judiciary Committee on Wednesday as part of an investigation into whether the department had been used for political purposes. He told the committee that the Justice Department's career lawyers believed that a proposed merger between MedMen and PharmaCann required no further antitrust investigation. In contrast, William Barr mobilized the Antitrust Division's leadership and ordered a full investigation, requesting thousands of documents, cell phone records, computer hard drive images and entire copies of mobile devices from the companies, and answering dozens of detailed questions on a wide range of business interests.
In addition to the MedMen - PharmaCann merger, a dozen other mergers and acquisitions were scrutinized.
«At one point, cannabis investigations accounted for five of the eight active merger investigations in the office that is responsible for the transportation, energy and agriculture sectors of the U.S. economy,» said Elias. «The investigations were so numerous that personnel from other bureaus were mobilized to assist, including telecommunications, technology and media.»
In his written testimony, Elias said that while responding to internal concerns about the investigations, Assistant Attorney General for the Antitrust Division Makan Delrahim «acknowledged that the investigations were motivated by the fact that the cannabis industry was unpopular »on the fifth floor«,» a reference to William Barr's offices.
-
Cannabis in France3 weeks ago
France Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Cannabis in Europe2 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Business4 weeks ago
Eight years after legalization, South African cannabis is still waiting for its legal market
-
Cannabis in France4 weeks ago
French Prime Minister Calls for Drug Testing in Government Ministries
-
Cannabis in Ukraine4 weeks ago
Ukraine Issues Its First Medical Cannabis Prescriptions to Veterans
-
Business3 weeks ago
Sanity Group is expanding its presence in Switzerland through a distribution agreement with Astrasana
-
Cannabis in the U.S.2 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Cannabis in Ireland2 weeks ago
The Irish Parliament recommends decriminalizing all drugs


You must be logged in to post a comment Login